摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-carboxymethyl-2-hydroxy-6-methyl-5-heptenoic acid | 244761-03-3

中文名称
——
中文别名
——
英文名称
2-carboxymethyl-2-hydroxy-6-methyl-5-heptenoic acid
英文别名
2-Carboxymethyl-2-hydroxy-6-methylhept-5-enoic Acid;2-hydroxy-2-(4-methylpent-3-enyl)butanedioic acid
2-carboxymethyl-2-hydroxy-6-methyl-5-heptenoic acid化学式
CAS
244761-03-3
化学式
C10H16O5
mdl
——
分子量
216.234
InChiKey
DRFNZQPZTGLTJC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.8
  • 重原子数:
    15
  • 可旋转键数:
    6
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.6
  • 拓扑面积:
    94.8
  • 氢给体数:
    3
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-carboxymethyl-2-hydroxy-6-methyl-5-heptenoic acid甲酸 作用下, 以 二氯甲烷 为溶剂, 反应 12.0h, 以100%的产率得到2-carboxymethyl-6,6-dimethyl-2-tetrahydro-pyranecarboxylic acid
    参考文献:
    名称:
    The first semi-synthesis of enantiopure homoharringtonine via anhydrohomoharringtonine from a preformed chiral acyl moiety
    摘要:
    (2'R,3S,4S,5R)-(-)-齐墩果酸甲酯 2 由 cephalotaxine 直接酯化制得,采用适当取代的四氢吡喃甲酸的活化形式作为立体紧凑的手性侧链前体,随后通过选择性开环得到相应的 (2'R,3S,4S,5R)-(-)-anhydrohomoharringtonine 6。干酰基部分的两个对映体通过以下两种方法制备:一种方法是对适当取代的烯基 α-酮酯 7 进行不对称 α-羟基烷基化,然后进行酸性环化;另一种方法是通过对 (-)-金鸡纳碱形成非对映异构体来分离对应的外消旋混合物。外消旋 cephalotaxine 以及其两个对映体均由天然的部分外消旋的 (-)-cephalotaxine 1 制得。版权 © 1999 Elsevier Science Ltd,保留所有权利。
    DOI:
    10.1016/s0040-4039(99)00327-5
  • 作为产物:
    参考文献:
    名称:
    The first semi-synthesis of enantiopure homoharringtonine via anhydrohomoharringtonine from a preformed chiral acyl moiety
    摘要:
    (2'R,3S,4S,5R)-(-)-齐墩果酸甲酯 2 由 cephalotaxine 直接酯化制得,采用适当取代的四氢吡喃甲酸的活化形式作为立体紧凑的手性侧链前体,随后通过选择性开环得到相应的 (2'R,3S,4S,5R)-(-)-anhydrohomoharringtonine 6。干酰基部分的两个对映体通过以下两种方法制备:一种方法是对适当取代的烯基 α-酮酯 7 进行不对称 α-羟基烷基化,然后进行酸性环化;另一种方法是通过对 (-)-金鸡纳碱形成非对映异构体来分离对应的外消旋混合物。外消旋 cephalotaxine 以及其两个对映体均由天然的部分外消旋的 (-)-cephalotaxine 1 制得。版权 © 1999 Elsevier Science Ltd,保留所有权利。
    DOI:
    10.1016/s0040-4039(99)00327-5
点击查看最新优质反应信息

文献信息

  • [EN] DIOXOLANONE INTERMEDIATE USEFUL IN THE SYNTHESIS OF HOMOHARRINGTONINE<br/>[FR] INTERMÉDIAIRE DE DIOXOLANONE UTILE DANS LA SYNTHÈSE DE L'HOMOHARRINGTONINE
    申请人:INDENA SPA
    公开号:WO2018019549A1
    公开(公告)日:2018-02-01
    The invention discloses 2-((2R,4R)-4-(4-(benzyloxy)-4-methylpent-2-yn-1-yl)-2-(tert-butyl)-5-oxo-1,3-dioxolan-4-yl)acetic acid of formula (XIX), a process for its preparation and processes for its conversion into enantiomerically pure (R)-2-(2-methoxy-2-oxoethyl)-6,6-dimethyltetrahydro-2H-pyran-2-carboxylic acid of formula (I), a molecule useful for the synthesis of Homoharringtonine.
    该发明公开了式(XIX)的2-((2R,4R)-4-(4-(苄氧基)-4-甲基戊-2-炔-1-基)-2-(叔丁基)-5-氧代-1,3-二氧杂环戊-4-基)乙酸,其制备方法以及将其转化为式(I)的对映纯(R)-2-(2-甲氧基-2-氧代乙基)-6,6-二甲基四氢-2H-吡喃-2-羧酸的方法,该分子可用于合成吉非替林。
  • Process for Preparing 2-Methoxycarbonylmethyl-6,6-Dimethyl-2-Tetrahydropyran Carboxylic Acid
    申请人:Ferrari Massimo
    公开号:US20090043093A1
    公开(公告)日:2009-02-12
    Process for preparing 2-methoxycarbonylmethyl-6,6-dimethyl-2-tetrahydropyran carboxylic acid (I) comprising: a) Reaction of 5-bromo-2-methyl-2-pentene (III) with magnesium and then diethyloxalate to obtain ethyl-2-oxo-6-methyl-5-heptenoate (IV); b) Reaction of ethyl-2-oxo-6-methyl-5-heptenoate (IV) with an alkali amide and methyl acetate to obtain ethyl-2-methoxycarbonylmethyl-2-hydroxy-6-methyl-5-heptenoate (V); c) Reaction of ethyl-2-methoxycarbonylmethyl-2-hydroxy-6-methyl-5-heptenoate (V) with an alkali metal hydroxide to obtain the corresponding 2-carboxymethyl-2-hydroxy-6-methyl-5-heptenoic acid (VI); d) Cyclisation of 2-carboxymethyl-2-hydroxy-6-methyl-5-heptenoic acid (VI) with formic acid to give 2-carboxymethyl-6,6-dimethyl-2-tetrahydropyrancarboxylic acid (VII); e) Monoesterification of 2-carboxymethyl-6,6-dimethyl-2-tetrahydropyrancarboxylic acid (VII) to 2-methoxycarbonylmethyl-6,6-dimethyl-2-tetrahydropyran carboxylic acid (I), characterised in that in stage (e) the 2-methoxycarbonylmethyl-6,6-dimethyl-2-tetrahydropyran carboxylic acid (I) is purified by means of the formation of the corresponding salt with cyclohexylamine (IA).
    制备2-甲氧羰基甲基-6,6-二甲基-2-四氢吡喃羧酸(I)的过程包括: a)将5-溴-2-甲基-2-戊烯(III)与镁反应,然后与草酸二乙酯反应,得到乙酸乙酯-2-氧代-6-甲基-5-庚烯酸酯(IV); b)将乙酸乙酯-2-氧代-6-甲基-5-庚烯酸酯(IV)与碱金属酰胺和乙酸甲酯反应,得到乙酸乙酯-2-甲氧羰基甲基-2-羟基-6-甲基-5-庚烯酸酯(V); c)将乙酸乙酯-2-甲氧羰基甲基-2-羟基-6-甲基-5-庚烯酸酯(V)与碱金属氢氧化物反应,得到相应的2-羧甲基-2-羟基-6-甲基-5-庚烯酸(VI); d)将2-羧甲基-2-羟基-6-甲基-5-庚烯酸(VI)与甲酸环化,得到2-羧甲基-6,6-二甲基-2-四氢吡喃羧酸(VII); e)将2-羧甲基-6,6-二甲基-2-四氢吡喃羧酸(VII)进行单酯化反应,得到2-甲氧羰基甲基-6,6-二甲基-2-四氢吡喃羧酸(I),其特征在于在阶段(e)中,通过与环己胺(IA)形成相应的盐来纯化2-甲氧羰基甲基-6,6-二甲基-2-四氢吡喃羧酸(I)。
  • Novel cephalotaxane derivatives and process for their preparation
    申请人:——
    公开号:US20020045750A1
    公开(公告)日:2002-04-18
    The present invention concerns a new general process for asymetric hemisynthesis of harringtonines and their analogs, that are alcaloïds used in chimiotherapy. This process comprises direct esterification of a natural cephalotaxine with an acylating compound constituted of a side chain precursor which backbone and fonctionalization are entirely preformed.
    本发明涉及一种新的用于制备哈林顿碱及其类似物的不对称半合成的通用过程,这些化合物是用于化疗的生物碱。该过程包括将天然的头孢松碱与由侧链前体组成的酰化化合物直接酯化,该侧链前体的骨架和功能化已经完全形成。
  • Cephalotaxane derivatives and their processes of preparation and purification
    申请人:Robin Jean-Pierre
    公开号:US20050090484A1
    公开(公告)日:2005-04-28
    The present invention concerns a new general process for asymmetric hemisynthesis of harringtonines and their analogs, that are alkaloids used in chemotherapy. This process comprises direct esterification of a natural cephalotaxine with an acylating compound constituted of a side chain precursor which backbone and functionalization are entirely preformed. The invention also concerns a natural, synthetic or semi-synthetic harringtonines including their tautomeric forms and their salts of the following formula: wherein n=2 (i.e. harringtonine) or n=3 (i.e. homoharringtonine), in which the total content of impurities, possibly including enantiomeric forms, is lower than 1%, and/or the content of the major impurity is lower than 0.9%, and/or the chromatographic assay exhibits a harringtonines content higher than 97.5%.
    本发明涉及一种新的不对称半合成哈林顿碱及其类似物的通用工艺,这些碱是用于化疗的生物碱。该工艺包括将天然的头孢松与一个酰化化合物直接酯化,该化合物由一个侧链前体构成,其主干和功能化已经完全形成。该发明还涉及以下式子的天然、合成或半合成哈林顿碱及其互变异构体和盐:其中n=2(即哈林顿碱)或n=3(即同型哈林顿碱),其中可能包括对映异构体在内的总杂质含量低于1%,和/或主要杂质含量低于0.9%,和/或色谱测定显示哈林顿碱含量高于97.5%。
  • Process for preparing 2-methoxycarbonylmethyl-6,6-dimethyl-2-tetrahydropyran carboxylic acid
    申请人:Erregierre S.p.A.
    公开号:US08008514B2
    公开(公告)日:2011-08-30
    Process for preparing 2-methoxycarbonylmethyl-6,6-dimethyl-2-tetrahydropyran carboxylic acid (I) comprising: a) Reaction of 5-bromo-2-methyl-2-pentene (III) with magnesium and then diethyloxalate to obtain ethyl-2-oxo-6-methyl-5-heptenoate (IV); b) Reaction of ethyl-2-oxo-6-methyl-5-heptenoate (IV) with an alkali amide and methyl acetate to obtain ethyl-2-methoxycarbonylmethyl-2-hydroxy-6-methyl-5-heptenoate (V); c) Reaction of ethyl-2-methoxycarbonylmethyl-2-hydroxy-6-methyl-5-heptenoate (V) with an alkali metal hydroxide to obtain the corresponding 2-carboxymethyl-2-hydroxy-6-methyl-5-heptenoic acid (VI); d) Cyclisation of 2-carboxymethyl-2-hydroxy-6-methyl-5-heptenoic acid (VI) with formic acid to give 2-carboxymethyl-6,6-dimethyl-2-tetrahydropyrancarboxylic acid (VII); e) Monoesterification of 2-carboxymethyl-6,6-dimethyl-2-tetrahydropyrancarboxylic acid (VII) to 2-methoxycarbonylmethyl-6,6-dimethyl-2-tetrahydropyran carboxylic acid (I), characterised in that in stage (e) the 2-methoxycarbonylmethyl-6,6-dimethyl-2-tetrahydropyran carboxylic acid (I) is purified by means of the formation of the corresponding salt with cyclohexylamine (IA).
    制备2-甲氧羰基甲基-6,6-二甲基-2-四氢吡喃羧酸(I)的过程包括: a)5-溴-2-甲基-2-戊烯(III)与镁反应,然后与乙酰乙酸二乙酯反应,得到乙酸乙酯-2-氧代-6-甲基-5-庚烯酸乙酯(IV); b)乙酸乙酯-2-氧代-6-甲基-5-庚烯酸乙酯(IV)与碱金属酰胺和乙酸甲酯反应,得到乙酸乙酯-2-甲氧羰基甲基-2-羟基-6-甲基-5-庚烯酸乙酯(V); c)乙酸乙酯-2-甲氧羰基甲基-2-羟基-6-甲基-5-庚烯酸乙酯(V)与碱金属氢氧化物反应,得到相应的2-羧甲基-2-羟基-6-甲基-5-庚烯酸(VI); d)2-羧甲基-2-羟基-6-甲基-5-庚烯酸(VI)与甲酸环化,得到2-羧甲基-6,6-二甲基-2-四氢吡喃羧酸(VII); e)2-羧甲基-6,6-二甲基-2-四氢吡喃羧酸(VII)单酯化为2-甲氧羰基甲基-6,6-二甲基-2-四氢吡喃羧酸(I),其特征在于在步骤(e)中,通过与环己胺形成相应的盐来纯化2-甲氧羰基甲基-6,6-二甲基-2-四氢吡喃羧酸(I)。
查看更多

同类化合物

(5β,6α,8α,10α,13α)-6-羟基-15-氧代黄-9(11),16-二烯-18-油酸 (3S,3aR,8aR)-3,8a-二羟基-5-异丙基-3,8-二甲基-2,3,3a,4,5,8a-六氢-1H-天青-6-酮 (2Z)-2-(羟甲基)丁-2-烯酸乙酯 (2S,4aR,6aR,7R,9S,10aS,10bR)-甲基9-(苯甲酰氧基)-2-(呋喃-3-基)-十二烷基-6a,10b-二甲基-4,10-dioxo-1H-苯并[f]异亚甲基-7-羧酸盐 (+)顺式,反式-脱落酸-d6 龙舌兰皂苷乙酯 龙脑香醇酮 龙脑烯醛 龙脑7-O-[Β-D-呋喃芹菜糖基-(1→6)]-Β-D-吡喃葡萄糖苷 龙牙楤木皂甙VII 龙吉甙元 齿孔醇 齐墩果醛 齐墩果酸苄酯 齐墩果酸甲酯 齐墩果酸乙酯 齐墩果酸3-O-alpha-L-吡喃鼠李糖基(1-3)-beta-D-吡喃木糖基(1-3)-alpha-L-吡喃鼠李糖基(1-2)-alpha-L-阿拉伯糖吡喃糖苷 齐墩果酸 beta-D-葡萄糖酯 齐墩果酸 beta-D-吡喃葡萄糖基酯 齐墩果酸 3-乙酸酯 齐墩果酸 3-O-beta-D-葡吡喃糖基 (1→2)-alpha-L-吡喃阿拉伯糖苷 齐墩果酸 齐墩果-12-烯-3b,6b-二醇 齐墩果-12-烯-3,24-二醇 齐墩果-12-烯-3,21,23-三醇,(3b,4b,21a)-(9CI) 齐墩果-12-烯-3,11-二酮 齐墩果-12-烯-2α,3β,28-三醇 齐墩果-12-烯-29-酸,3,22-二羟基-11-羰基-,g-内酯,(3b,20b,22b)- 齐墩果-12-烯-28-酸,3-[(6-脱氧-4-O-b-D-吡喃木糖基-a-L-吡喃鼠李糖基)氧代]-,(3b)-(9CI) 鼠特灵 鼠尾草酸醌 鼠尾草酸 鼠尾草酚酮 鼠尾草苦内脂 黑蚁素 黑蔓醇酯B 黑蔓醇酯A 黑蔓酮酯D 黑海常春藤皂苷A1 黑檀醇 黑果茜草萜 B 黑五味子酸 黏黴酮 黏帚霉酸 黄黄质 黄钟花醌 黄质醛 黄褐毛忍冬皂苷A 黄蝉花素 黄蝉花定